Solara Active Pharma Sciences Ltd

The aforementioned inspection was conducted between August 25th to 29th, 2025. The agency has issued an EIR (Establishment Inspection Report) on 18th Nov 2025 and determined that the inspection classification of the facility is 'voluntary action indicated (VAI)' and concluded this inspection as closed. Sandeep Rao, MD & CEO said 'We have successfully completed the FDA inspection at our Mangalore facility between 25th to 29th Aug 2025. At the end of the inspection, two Form FDA 483 inspectional observations were issued by the investigator. The observations were procedural in nature. We had submitted our formal response to FDA well within the timeline set by the agency and the agency has issued an EIR and concluded that the inspection is closed.' Solara Active Pharma Sciences is a pure play global API manufacturer supported by R&D and manufacturing facilities. The scrip declined 2.05% to currently trade at Rs 561.05 on the BSE. Powered by Capital Market - Live

Solara Active Pharma Sciences announced that its multi-product manufacturing facility at Mangalore, Karnataka has successfully completed the inspection carried out by the US Food and Drug Administration (US FDA) between 25 to 29 August 2025. The Agency has issued an EIR (Establishment Inspection Report) on 18th Nov 2025 and determined that the inspection classification of the facility is 'Voluntary Action Indicated (VAI)' and concluded this inspection as closed.Powered by Capital Market - Live

Net loss of Solara Active Pharma Sciences reported to Rs 10.10 crore in the quarter ended September 2025 as against net profit of Rs 8.01 crore during the previous quarter ended September 2024. Sales declined 9.63% to Rs 313.54 crore in the quarter ended September 2025 as against Rs 346.95 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales313.54346.95 -10 OPM %11.0817.67 - PBDT14.3933.35 -57 PBT-10.108.01 PL NP-10.108.01 PL Powered by Capital Market - Live

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company on 5 November 2025.Powered by Capital Market - Live

Solara Active Pharma Sciences announced that Crisil ESG Ratings & Analytics has assigned an Environmental, Social and Governance (ESG) rating of 'Crisil ESG 56' - under 'Adequate' category (improved from 'Crisil ESG 53' for the period ended 31 March 2024). Powered by Capital Market - Live

Solara Active Pharma Sciences Ltd fell 4.17% today to trade at Rs 645. The BSE Healthcare index is down 1.85% to quote at 43175.04. The index is down 2.04 % over last one month. Among the other constituents of the index, Strides Pharma Science Ltd decreased 4.17% and Gland Pharma Ltd lost 3.84% on the day. The BSE Healthcare index went down 2.16 % over last one year compared to the 5.64% fall in benchmark SENSEX. Solara Active Pharma Sciences Ltd has added 6.23% over last one month compared to 2.04% fall in BSE Healthcare index and 0.25% rise in the SENSEX. On the BSE, 8051 shares were traded in the counter so far compared with average daily volumes of 34893 shares in the past one month. The stock hit a record high of Rs 885.95 on 02 Dec 2024. The stock hit a 52-week low of Rs 441.1 on 04 Mar 2025.Powered by Capital Market - Live

Hindustan Copper Ltd, KIOCL Ltd, Inox Green Energy Services Ltd and Newgen Software Technologies Ltd are among the other gainers in the BSE's 'A' group today, 25 September 2025.Solara Active Pharma Sciences Ltd spiked 9.08% to Rs 702.8 at 11:47 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 1.36 lakh shares were traded on the counter so far as against the average daily volumes of 29272 shares in the past one month. Hindustan Copper Ltd surged 6.53% to Rs 328.5. The stock was the second biggest gainer in 'A' group. On the BSE, 18.37 lakh shares were traded on the counter so far as against the average daily volumes of 6.59 lakh shares in the past one month. KIOCL Ltd soared 5.26% to Rs 467.35. The stock was the third biggest gainer in 'A' group. On the BSE, 1.77 lakh shares were traded on the counter so far as against the average daily volumes of 1.42 lakh shares in the past one month. Inox Green Energy Services Ltd advanced 5.00% to Rs 205.9. The stock was the fourth biggest gainer in 'A' group. On the BSE, 2.29 lakh shares were traded on the counter so far as against the average daily volumes of 1.38 lakh shares in the past one month. Newgen Software Technologies Ltd added 4.73% to Rs 915.8. The stock was the fifth biggest gainer in 'A' group. On the BSE, 3.64 lakh shares were traded on the counter so far as against the average daily volumes of 58981 shares in the past one month. Powered by Capital Market - Live

Solara Active Pharma Sciences announced that the Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live

Net profit of Solara Active Pharma Sciences reported to Rs 10.52 crore in the quarter ended June 2025 as against net loss of Rs 13.46 crore during the previous quarter ended June 2024. Sales declined 12.20% to Rs 319.15 crore in the quarter ended June 2025 as against Rs 363.49 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales319.15363.49 -12 OPM %17.8711.53 - PBDT34.1011.61 194 PBT10.52-13.46 LP NP10.52-13.46 LP Powered by Capital Market - Live

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company on 25 July 2025.Powered by Capital Market - Live